Form D · Private Equity Fund
OrbiMed Royalties V Private Investors, LLC
New York, NY · CIK 0002078379
Offering snapshot reported Aug 8, 2025 · SEC filing
- Reported sold
- $49M Indefinite offering
- Investors reported
- 70 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jul 30, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 8, 2025 | Initial | $48,975,000 | No comparison | 70 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $661K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-554066
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None | J.P. Morgan Securities LLC · CRD 79 |
Source: Form D, filed Aug 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Grant Cellier | Director |
| N/A J.P. Morgan Private Investments Inc. | Executive, Promoter |
| Robert Meschi | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
J.P. Morgan Private Investments Inc. 383 Madison Avenue
New York, NY, 10179
New York, NY, 10179